当前位置:首页 - 行情中心 - 迈普医学(301033) - 财务分析

迈普医学

(301033)

  

流通市值:38.94亿  总市值:46.23亿
流通股本:5646.91万   总股本:6704.96万

迈普医学(301033)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.76亿元,每股收益1.15元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益75137.08万元,未分配利润19435.69万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产84457.74万元,负债9320.67万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入249,228,235.32157,777,674.1473,703,893.55278,442,127.39
营业总成本170,015,989.07107,860,363.5848,479,325.85202,578,024.19
其他经营收益
营业利润88,980,940.0556,869,400.5528,535,059.6891,722,045.56
利润总额87,778,764.5954,813,793.828,315,992.3893,157,094.38
净利润75,854,036.8447,299,142.724,162,30778,854,230.23
每股收益
其他综合收益100,175.2158,942.9751,005.197,467.26
综合收益总额75,954,212.0447,458,085.6724,213,312.1978,861,697.49
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计322,182,786.75289,597,505.17300,948,007.36312,406,407.83
非流动资产:
非流动资产合计522,394,643.03515,502,367.9515,021,909.02486,823,917.01
资产总计844,577,429.78805,099,873.07815,969,916.38799,230,324.84
流动负债:
流动负债合计45,514,788.6640,051,096.0337,478,975.3147,476,282.31
非流动负债:
非流动负债合计47,691,877.2348,734,783.5950,536,544.5452,089,349.57
负债合计93,206,665.8988,785,879.6288,015,519.8599,565,631.88
所有者权益(或股东权益):
归属于母公司股东权益合计751,370,763.89716,313,993.45727,954,396.53699,664,692.96
股东权益合计751,370,763.89716,313,993.45727,954,396.53699,664,692.96
负债和股东权益合计844,577,429.78805,099,873.07815,969,916.38799,230,324.84
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计285,881,257.06185,830,158.293,021,906.35341,053,216.86
经营活动现金流出小计202,123,068.5129,309,204.963,817,159.32224,668,863.87
经营活动产生的现金流量净额83,758,188.5656,520,953.329,204,747.03116,384,352.99
投资活动产生的现金流量:
投资活动现金流入小计475,253,588.15344,918,169.33164,037,204.41436,529,989.6
投资活动现金流出小计542,900,968.23385,221,119.41221,823,777.22444,859,918.17
投资活动产生的现金流量净额-67,647,380.08-40,302,950.08-57,786,572.81-8,329,928.57
筹资活动产生的现金流量:
筹资活动现金流入小计12,955,659.6--9,312,192
筹资活动现金流出小计40,653,893.0140,488,142.71510,502.290,981,760.1
筹资活动产生的现金流量净额-27,698,233.41-40,488,142.71-510,502.2-81,669,568.1
汇率变动对现金及现金等价物的影响476,542.53495,324.34169,295.21156,134.77
现金及现金等价物净增加额-11,110,882.4-23,774,815.15-28,923,032.7726,540,991.09
期末现金及现金等价物余额42,106,718.8729,442,786.1224,294,568.553,217,601.27
补充资料:
现金及现金等价物的净增加额--23,774,815.15-26,540,991.09
最新报告期:2025-10-30
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
甬兴证券彭波,徐昕1.572.042.622025-10-30
华安证券钱琨,谭国超1.642.343.432025-10-28
华创证券郑辰,李婵娟1.702.373.312025-10-18
华创证券郑辰,李婵娟1.702.373.312025-09-15
甬兴证券彭波,徐昕1.582.052.642025-08-26
TOP↑